GOLDEN, Colo. — October 2, 2024 — PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling technology, today announced that Wouter Latour, M.D., has joined the company as Chief Executive Officer (CEO). Latour also joins the PharmaJet board of directors. He succeeds Chris
View
GOLDEN, Colo. — September 17, 2024 — PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling technology, today announced that it has entered into a long-term license and supply agreement with Scancell Holdings plc (LSE – SCLP.L) to use the US FDA 510(k)-cleared
View
GOLDEN, Colo. — June 27, 2024 — PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its innovative delivery systems, today announced that their Tropis® Intradermal (ID) Needle-free System will be used in a house-to-house polio immunization campaign. With an aim of significantly reducing the
View
GOLDEN, Colo. — April 24, 2024 — PharmaJet®, a company that strives to improve the performance and outcomes of medicines with its innovative delivery systems, today announced the Nature publication of Gennova Biopharmaceutical’s Phase 2/3 clinical trial conducted to evaluate the safety and immunogenicity of its novel samRNA-based Covid-19 vaccine
View
GOLDEN, Colo. — April 1, 2024 —PharmaJet®, a company that strives to improve the performance and outcomes of medicines with its innovative delivery systems, today announced the formation of two Scientific Advisory Boards (SAB) comprised of leading pharmaceutical industry experts in immunology, cancer, research, and policy shaping. The Boards will
View
GOLDEN, Colo. — November 16, 2023 — PharmaJet®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced the start of the first human clinical trial for a Venezuelan Equine Encephalitis (VEE) vaccine delivered with PharmaJet Precision Delivery Systems. The Phase
View
GOLDEN, Colo. — October 31, 2023 — PharmaJet®, a company that engineers precision delivery systems that overcome the challenges of vaccines and pharmaceuticals delivery, today announced that it received a strategic investment from the Daicel Corporation. This investment coincides with Daicel’s announcement of the establishment of a new company, Daicel
View
GOLDEN, Colo. — October 24, 2023 — PharmaJet® , a company that engineers precision delivery systems that overcome the challenges of vaccines and pharmaceuticals delivery, today announced the implementation of a study in Nigeria to evaluate the impact of intradermal vaccine administration of fractional inactivated poliovirus vaccine (fIPV) using their
View
GOLDEN, Colo. — September 28, 2023 — PharmaJet®, a company that engineers precision delivery systems that overcome the challenges of vaccines and pharmaceuticals delivery, today announced that its partner, Scancell, has received positive data from the first stage in its Phase 2 clinical study for treatment of patients with unresectable
View
Load more